MEF2D and ovarian cancer: To examine the effects of variants on activity of the MEF2D promoter, we tested the effects of the four candidate outcome variants in MEF2D PRE1 on promoter activity in OVCAR8 and JAM cells, the two ovarian cancer cell lines in which MEF2D was most highly expressed (Supplementary Figure 1).